Primate skin allotransplantation with anti-CD154 monotherapy
- 1 February 2001
- journal article
- Published by Elsevier in Transplantation Proceedings
- Vol. 33 (1-2) , 675-676
- https://doi.org/10.1016/s0041-1345(00)02197-7
Abstract
No abstract availableThis publication has 6 references indexed in Scilit:
- Treatment of Allograft Recipients with Donor-Specific Transfusion and Anti-CD154 Antibody Leads to Deletion of Alloreactive CD8+ T Cells and Prolonged Graft Survival in a CTLA4-Dependent MannerThe Journal of Immunology, 2000
- Long-term survival and function of intrahepatic islet allografts in rhesus monkeys treated with humanized anti-CD154Proceedings of the National Academy of Sciences, 1999
- Treatment with humanized monoclonal antibody against CD154 prevents acute renal allograft rejection in nonhuman primatesNature Medicine, 1999
- Long-term survival of skin allografts induced by donor splenocytes and anti-CD154 antibody in thymectomized mice requires CD4(+) T cells, interferon-gamma, and CTLA4.Journal of Clinical Investigation, 1998
- CTLA4-Ig and anti-CD40 ligand prevent renal allograft rejection in primatesProceedings of the National Academy of Sciences, 1997
- Long-term acceptance of skin and cardiac allografts after blocking CD40 and CD28 pathwaysNature, 1996